Holen Sie sich die Stockscreener-App
587.48
2.57%
14.74
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$572.74
Offen:
$573
24-Stunden-Volumen:
1.93M
Relative Volume:
0.98
Marktkapitalisierung:
$220.72B
Einnahmen:
$43.74B
Nettoeinkommen (Verlust:
$6.58B
KGV:
33.94
EPS:
17.3072
Netto-Cashflow:
$6.11B
1W Leistung:
+1.52%
1M Leistung:
+5.29%
6M Leistung:
+47.50%
1J Leistung:
+13.83%
1-Tages-Spanne:
$569.55
$589.85
1-Wochen-Bereich:
$556.46
$589.85
52-Wochen-Spanne:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? - Yahoo Finance
Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034 - GlobeNewswire Inc.
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing* - Food Industry Executive
Genomic Biomarker Market By Top Companies Illumina,Thermo - openPR.com
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer - BioSpace
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth - The Globe and Mail
TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner - TradingView
Thermo Fisher Expands U.S. Cell & Gene Therapy Network with New Advanced Therapies Center in Philadelphia - Voice Of HealthCare
Can Thermo Fisher Scientific Inc. stock sustain institutional interestMarket Risk Analysis & Short-Term High Return Ideas - newser.com
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following EXENT System Clearance and New Philly Center Opening – Learn Why - Yahoo Finance
Will Thermo Fisher Scientific Inc stock outperform benchmarksSell Signal & Safe Entry Point Identification - newser.com
Will Thermo Fisher Scientific Inc. (TN8) stock sustain bullish trend into 2025Market Trend Report & Consistent Income Trade Ideas - newser.com
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock behaves in tightening cyclesTrade Exit Summary & Safe Entry Zone Identification - newser.com
Institutions Love These 3 Companies, Should You As Well? - Finviz
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two - PharmTech.com
Thermo Fisher unveils Advanced Therapies Collaboration Centre in US - BioSpectrum Asia
Why Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock signals breakout potential2025 Analyst Calls & AI Driven Stock Reports - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock expanding market penetration2025 Market Outlook & Safe Capital Growth Tips - newser.com
How robust is Thermo Fisher Scientific Inc stock financial positionBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
Is Thermo Fisher Scientific Inc stock supported by strong fundamentalsJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development - BioSpace
Is Thermo Fisher Scientific Inc. (TN8) stock among top earnings playsJuly 2025 Gainers & Pattern Based Trade Signal System - newser.com
Will Thermo Fisher Scientific Inc. (TN8) stock outperform global peersJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com
Will Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock beat value stocksQuarterly Earnings Report & High Accuracy Trade Alerts - newser.com
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs - citybiz
Is Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock attractive for growth funds2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Why Thermo Fisher chose Philly for its new East Coast collaboration center for biotech startups - The Business Journals
Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub - rdworldonline.com
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Philadelphia - Contract Pharma
These 3 Stocks Are Using Buybacks to Signal Market Confidence - Finviz
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
Thermo Fisher Scientific Digital Transformation Strategy Analysis Report 2025: Accelerators, Incubators, and Other Innovation ProgramsResearchAndMarkets.com - Bluefield Daily Telegraph
Moody’s upgrades Thermo Fisher Scientific to A2, outlook stable - Investing.com
Thermo Fisher Scientific Inc. (NYSE:TMO) Is a Favorite Amongst Institutional Investors Who Own 89% - 富途牛牛
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder - The AI Journal
Thermo Fisher Scientific launches CorEvitas clinical registry in myasthenia gravis - PharmaLive
Why Thermo Fisher Scientific Inc. (TN8) stock fits value portfoliosAnalyst Upgrade & Verified Swing Trading Watchlists - newser.com
Will Thermo Fisher Scientific Inc. (TN8) stock split increase liquidityMarket Movement Recap & Risk Controlled Stock Alerts - newser.com
A Closer Look at Thermo Fisher Scientific's (TMO) Valuation After Recent Share Price Strength - simplywall.st
Is Thermo Fisher Scientific Inc. (TN8) stock considered safe havenJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Can Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock expand revenue streamsTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock supported by strong fundamentalsWeekly Earnings Recap & Real-Time Stock Price Movement Reports - newser.com
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock gains from tech spendingJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now - sharewise.com
Is Thermo Fisher Scientific Inc stock in buy zone after pullbackDividend Hike & Daily Chart Pattern Signal Reports - newser.com
Insider Sell: Lisa Britt Sells Shares of Thermo Fisher Scientifi - GuruFocus
Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more - Medical Marketing and Media
Thermo Fisher Scientific Insider Sold Shares Worth $2,756,920, According to a Recent SEC Filing - MarketScreener
Will Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock hit analyst forecastsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Why Thermo Fisher Scientific Inc. (TN8) stock remains top ratedTrade Signal Summary & Risk Controlled Stock Alerts - Fundação Cultural do Pará
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific - Nasdaq
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):